BSX vs COLL · P/E 20, rev $16.75B vs P/E 17, rev $181.9M
Boston Scientific Corp (BSX) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BSX and COLL stock pages for the full models.
Not investment advice.